BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ikoma N, Roland CL, Torres KE, Chiang YJ, Wang WL, Somaiah N, Mann GN, Hunt KK, Cormier JN, Feig BW. Salvage Surgery for Recurrent Retroperitoneal Well-Differentiated Liposarcoma: Early Reoperation may not Provide Benefit. Ann Surg Oncol. 2018;25:2193-2200. [PMID: 29520652 DOI: 10.1245/s10434-018-6417-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Tranberg A, Nielsen MK, Sørensen FB, Thygesen K, Verwaal VJ, Sørensen MM, Christensen HK, Funder JA. Intraabdominal and retroperitoneal soft-tissue sarcomas – Surgical treatment and outcomes. Surgical Oncology 2022. [DOI: 10.1016/j.suronc.2022.101781] [Reference Citation Analysis]
2 Ishii K, Yokoyama Y, Nishida Y, Koike H, Yamada S, Kodera Y, Sassa N, Gotoh M, Nagino M. Characteristics of primary and repeated recurrent retroperitoneal liposarcoma: outcomes after aggressive surgeries at a single institution. Jpn J Clin Oncol 2020;50:1412-8. [PMID: 32699905 DOI: 10.1093/jjco/hyaa126] [Reference Citation Analysis]
3 Gamboa AC, Gronchi A, Cardona K. Soft‐tissue sarcoma in adults: An update on the current state of histiotype‐specific management in an era of personalized medicine. CA A Cancer J Clin 2020;70:200-29. [DOI: 10.3322/caac.21605] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 19.5] [Reference Citation Analysis]
4 Ikoma N, Feig BW. ASO Author Reflections: Recurrent Retroperitoneal Well-Differentiated Liposarcoma. Ann Surg Oncol 2019;26:543-4. [PMID: 30556116 DOI: 10.1245/s10434-018-7039-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Patkar S, Kattepur AK, Khanna N, Bajpai J. Retroperitoneal Sarcomas: a Current Review on Management. Indian J Surg Oncol. [DOI: 10.1007/s13193-022-01520-y] [Reference Citation Analysis]
6 Baia M, Ford SJ, Dumitra S, Samà L, Naumann DN, Spolverato G, Callegaro D. FOLLOW-UP of patients with retroperitoneal sarcoma. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.02.016] [Reference Citation Analysis]
7 Swallow CJ. Strategic Delay: Histology- and Biology-Driven Decision-Making in Recurrent Retroperitoneal Sarcoma. Ann Surg Oncol 2018;25:2117-9. [DOI: 10.1245/s10434-018-6472-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Masaki N, Onozawa M, Inoue T, Kurobe M, Kawai K, Miyazaki J. Clinical features of multiply recurrent retroperitoneal liposarcoma: A single-center experience. Asian J Surg 2021;44:380-5. [PMID: 33191070 DOI: 10.1016/j.asjsur.2020.10.015] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zheng QG, Sun ZH, Chen JJ, Li JC, Huang XJ. Paratesticular liposarcoma: Two case reports. World J Clin Cases 2021; 9(2): 457-462 [PMID: 33521115 DOI: 10.12998/wjcc.v9.i2.457] [Reference Citation Analysis]
10 Osuna-Soto J, Caro Cuenca T, Sanz-Zorrilla A, Torrecilla-Martínez A, Ortega Salas R, Leiva-Cepas F. Prognosis and survival of patients diagnosed with well-differentiated and dedifferentiated retroperitoneal liposarcoma. Cir Esp 2021:S0009-739X(21)00224-4. [PMID: 34366104 DOI: 10.1016/j.ciresp.2021.06.010] [Reference Citation Analysis]
11 Keung EZ, Rajkot N, Torres KE, Somaiah N, Hunt KK, Feig BW, Scally CP, Ikoma N, Roland CL. Evaluating the Impact of Surveillance Follow-Up Intervals in Patients Following Resection of Primary Well-Differentiated Liposarcoma of the Retroperitoneum. Ann Surg Oncol 2021;28:570-5. [PMID: 32409969 DOI: 10.1245/s10434-020-08582-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Glasbey JC, Bundred J, Tyler R, Hunt J, Tattersall H, Gourevitch D, Almond LM, Desai AD, Ford SJ. The impact of postoperative radiological surveillance intensity on disease free and overall survival from primary retroperitoneal, abdominal and pelvic soft-tissue sarcoma. Eur J Surg Oncol 2021;47:1771-7. [PMID: 33549374 DOI: 10.1016/j.ejso.2021.01.021] [Reference Citation Analysis]
13 Cananzi FCM, Ruspi L, Sicoli F, Minerva EM, Quagliuolo V. Did outcomes improve in retroperitoneal sarcoma surgery? Surg Oncol 2019;28:96-102. [PMID: 30851921 DOI: 10.1016/j.suronc.2018.11.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
14 Homsy P, Heiskanen I, Sampo M, Rönty M, Tukiainen E, Blomqvist C. Single centre 30-year experience in treating retroperitoneal liposarcomas. J Surg Oncol 2020;122:1163-72. [PMID: 32668067 DOI: 10.1002/jso.26118] [Reference Citation Analysis]
15 Siew CC, Cardona K, van Houdt WJ. Management of recurrent retroperitoneal sarcomas. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.06.008] [Reference Citation Analysis]
16 Li Y, Wu G, Zhang Y, Yang W, Wang X, Duan L, Niu L, Chen J, Zhou W, Liu J, Zhong H, Fan D, Hong L. Development and Validation of a Prognostic Model to Predict the Prognosis of Patients With Retroperitoneal Liposarcoma: A Large International Population-Based Cohort Study. Front Oncol 2022;12:857827. [PMID: 35719991 DOI: 10.3389/fonc.2022.857827] [Reference Citation Analysis]